RE: Focus IR interview:22 Jul 2024 23:29
Totally missed the point behind my posts. Let me try simplifying it further for you:
1) Stock A goes up and does raises at a discount each time, albeit at higher levels each time. So raises are done at 3p, 5p, 7p, 10p, 15p and so on.
2) Stock B remain stagnant at an average of 5p. Raises money at 3p, 4p 5p, 5p, and 5p.
What I am saying is that for all of Bres's undoubted plus points, the strategy for raising money at 5p each time is likely holding back the share price. I don't see why it should be lauded in any way. Saying that it's at a premium to the prevailing share price is also bs, when that share price has been kept suppressed by the strategy. Furthermore, the timing of the raise is also key to being able to say whether it's a discount or a premium. Had this raise been announced a couple of months ago, or the SI raise announced, when the share was trading nearer to 6p, it would have been a discount, not a premium.
So its nonsensical to talk of raises as minimising dilution or being done at a premium when the reality is that the share price is being pegged back by the strategy of fundraising here. Now, there might not be any alternative, but let's not describe it as some kind of victory over the market or outperformance, when having to raise at 5p each time! There is no point buying these shares above 5p, because the next fundraise at the 5p magic level will just undercut your holding (again) if you do. That is why this share is stuck at these levels. All imho and dyor